Overview

Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer

Status:
Enrolling by invitation

Trial end date:
2024-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the addition of 2 cycles of induction CapOx chemotherapy and 2 cycles of consolidation CapOx chemotherapy to standard chemoradiation improves 3-year disease-free survival in patients with locally advanced CRM"+" mid and low rectal cancer.

Phase:

Phase 3

Details

Lead Sponsor:

Blokhin's Russian Cancer Research Center

Treatments:

Capecitabine
Oxaliplatin